SCHEMBL11908091

SCHEMBL11908091

C=C(C)C(=O)Oc1cccc2c1C(=O)OC2=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.39
ALDH1A1 P00352 5/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 3/20 0.38
TTR P02766 2/20 0.38
MEN1 O00255 2/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ABCC4 O15439 1/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
HSP90AA1 P07900 1/20 0.38
CHRM2 P08172 1/20 0.38
HSP90AB1 P08238 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CHRM1 P11229 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2176042 0.85 KDM4E (0.50) ALDH1A1KMT2AMAPTHPGDTTR
SCHEMBL29117714 0.79 ELANE (0.45) ELANEALDH1A1KMT2AMAPTHPGD
SCHEMBL8622400 0.78 TTR (0.56) ELANEALDH1A1KMT2AMAPTHPGD
SCHEMBL6662940 0.78 TOP1 (0.60) ELANEALDH1A1KMT2AMAPTHPGD
SCHEMBL27957751 0.78 POLM (0.46) ELANEALDH1A1KMT2AMAPTHPGD
SCHEMBL29445347 0.78 TYMS (0.57) ELANEALDH1A1KMT2AMAPTHPGD
SCHEMBL966421 0.78 TYMS (0.57) ELANEALDH1A1KMT2AMAPTHPGD
SCHEMBL9663235 0.78 TDP1 (0.44) ELANEALDH1A1KMT2AMAPTHPGD
SCHEMBL28633753 0.77 KDM4E (0.50) ELANEALDH1A1KMT2AMAPTHPGD
SCHEMBL17460659 0.76 MAOA (0.56) ELANEALDH1A1KMT2AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11111320-B2 Addition-fragmentation oligomers 3M INNOVATIVE PROPERTIES COMPANY (US) 2021-09-07 US disclosed
EP-3326711-B1 GRAFT COPOLYMER FUNCTIONALIZED ARTICLE 3M INNOVATIVE PROPERTIES CO (US) 2021-07-07 EP disclosed
EP-2675783-B1 ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES CO (US) 2020-04-22 EP disclosed
EP-3259323-B1 ADDITION-FRAGMENTATION OLIGOMERS 3M INNOVATIVE PROPERTIES CO (US) 2020-02-26 EP disclosed
US-20200031961-A1 ADDITION-FRAGMENTATION OLIGOMERS 3M INNOVATIVE PROPERTIES CO (US) 2020-01-30 US disclosed
US-10479848-B2 Addition-fragmentation oligomers 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-11-19 US disclosed
US-10471398-B2 Graft copolymer functionalized article 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-11-12 US disclosed
US-10370322-B2 Addition-fragmentation agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-08-06 US disclosed
EP-3502092-A1 ADDITION-FRAGMENTATION AGENTS 3M Innovative Properties Company (US) 2019-06-26 EP disclosed
US-10144760-B2 Ligand functional substrates 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-12-04 US disclosed
WO-2014099317-A1 ADDITION-FRAGMENTATION OLIGOMERS 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-06-26 WO disclosed
EP-2691772-A1 LIGAND FUNCTIONAL SUBSTRATES 3M Innovative Properties Company (US) 2014-02-05 EP disclosed
EP-2675783-A1 ADDITION-FRAGMENTATION AGENTS 3M Innovative Properties Company (US) 2013-12-25 EP disclosed
WO-2013184366-A1 GRAFT COPOLYMER FUNCTIONALIZED ARTICLE 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-12-12 WO disclosed
WO-2013151739-A1 CROSSLINKABLE COMPOSITION COMPRISING PHOTOBASE GENERATORS 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-10-10 WO disclosed
WO-2013028401-A1 ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-02-28 WO disclosed
US-20120252091-A1 LIGAND FUNCTIONAL SUBSTRATES 3M INNOVATIVE PROPERTIES COMPANY 2012-10-04 US disclosed
WO-2012134636-A1 LIGAND FUNCTIONAL SUBSTRATES 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-10-04 WO disclosed
WO-2012112304-A1 ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-08-23 WO disclosed
US-20120208965-A1 ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES COMPANY 2012-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10479848-B2 Addition-fragmentation oligomers ECPAS, ITGA8, NBAS ELANE 2991/4885ALDH1A1 2212/4885KMT2A 2118/4885
US-10144760-B2 Ligand functional substrates PCNA, POLM, POLL ELANE 1666/4885ALDH1A1 4565/4885KMT2A 3710/4885
US-10370322-B2 Addition-fragmentation agents NR4A1, PARP14, MTX1 ELANE 748/4885ALDH1A1 3630/4885KMT2A 2178/4885
US-20200031961-A1 ADDITION-FRAGMENTATION OLIGOMERS ECPAS, ITGA8, NBAS ELANE 2991/4885ALDH1A1 2212/4885KMT2A 2118/4885
US-11111320-B2 Addition-fragmentation oligomers ECPAS, ITGA8, NBAS ELANE 2991/4885ALDH1A1 2212/4885KMT2A 2118/4885
US-20120252091-A1 LIGAND FUNCTIONAL SUBSTRATES PCNA, POLM, POLL ELANE 1666/4885ALDH1A1 4565/4885KMT2A 3710/4885
US-20120208965-A1 ADDITION-FRAGMENTATION AGENTS NR4A1, PARP14, MTX1 ELANE 748/4885ALDH1A1 3630/4885KMT2A 2178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.